3- indolizine derivatives as phosphoinositide 3-kinases inhibitors 机翻标题: 暂无翻译,请尝试点击翻译按钮。

源语言标题
(KR20170015487) 포스포이노시타이드 3-키나아제 억제제로서 인돌리진 유도체
公开号/公开日
KR20170015487 A 2017-02-08 [KR20170015487] / 2017-02-08
申请号/申请日
2017KR-7000424 / 2015-06-16
发明人
;
申请人
CHIESI FARMACEUTICI;
主分类号
IPC分类号
A61K-031/437A61K-031/497A61K-031/506A61K-031/519A61K-031/52C07D-471/04C07D-473/02C07D-487/04
摘要
(KR20170015487) Compounds of formula (I), defined herein, inhibit phosphoinositide 3-kinases (PI3K) and are useful for the treatment of disorders associated with PI3K enzymes.  (From US9527869 B2)
机翻摘要
暂无翻译结果,您可以尝试点击头部的翻译按钮。
地址
代理人
代理机构
;
优先权号
2014EP-0172764 2014-06-17 2015WO-EP63390 2015-06-16
主权利要求

        
法律状态
(KR20170015487) LEGAL DETAILS FOR KR20170015487  Actual or expected expiration date=2035-06-16    Legal state=ALIVE    Status=PENDING     Event publication date=2015-06-16  Event code=KR/APP  Event indicator=Pos  Event type=Examination events  Application details  Application country=KR KR20177000424  Application date=2015-06-16  Standardized application number=2017KR-7000424     Event publication date=2017-02-08  Event code=KR/A  Event type=Examination events  Published application  Publication country=KR  Publication number=KR20170015487  Publication stage Code=A  Publication date=2017-02-08  Standardized publication number=KR20170015487
专利类型码
A
国别省市代码
若您需要申请原文,请登录。

最新评论

暂无评论。

登录后可以发表评论

意见反馈
返回顶部